WilliamVWalshMD

Oncology • Worcester, MA

Associate Professor, Medicine, University Massachusetts Medical School

Join to view full profile

Dr. Walsh is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Walsh's full profile

Already have an account?

Office
55 Lake Ave N
Department Of Hematology/Oncology
Worcester, MA 01655
Phone+1 508-334-5539
Is this information wrong?

Education & Training

National Capital ConsortiumFellowship, Hematology and Medical Oncology, 1989 - 1992
National Capital Consortium (Walter Reed)Residency, Internal Medicine, 1985 - 1988
George Washington University School of Medicine and Health SciencesClass of 1985
Harvard CollegeB.A., Biochemistry and Molecular Biology , 1976 - 1980

Certifications & Licensure

MA State Medical License 1995 - 2024
CT State Medical License 1995 - 2012
MD State Medical License 1988 - 1995
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011

Clinical Trials

Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery Start of enrollment: 2007 Jun 01
Active, not recruiting
Phase 3
Pemetrexed Disodium With or Without Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV or Recurrent Non-Small Cell Lung Cancer Start of enrollment: 2006 Apr 01
Completed
Phase 2
Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer Start of enrollment: 2010 Oct 25
Completed
Phase 3
Erlotinib Hydrochloride Before Surgery in Treating Patients With Stage III Non-Small Cell Lung Cancer Start of enrollment: 2013 Nov 01
Terminated
Phase 2
Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches Start of enrollment: 2014 Nov 01
Completed
Phase 2
Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer Start of enrollment: 2014 Sep 01
Completed
Phase 2, Phase 3
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers Start of enrollment: 2015 Dec 29
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

Telehealth through the pandemic at a safety net hospital: observations and next steps for cancer care delivery.
Erin Thomas, Alice Kennedy, William Walsh, Michelle Carpentier, Hannah Adeyinka, Shyam Patel, Jonathan Gerber, Jan Cerny, Kriti Mittal> ;Frontiers in Public Health. 2023 Jan 1
10 citations
Coordination and optimization of FDG PET/CT and COVID-19 vaccination; Lessons learned in the early stages of mass vaccination.
Lacey J. McIntosh, Max P. Rosen, Kriti Mittal, Giles F. Whalen, Venu Bathini, Tasneem Ali, Kathryn Edmiston, William V. Walsh, Jonathan M. Gerber> ;Cancer Treatment Reviews. 2021 May 11
5 citations
The rates of second lung cancers and the survival of surgically-resected second primary lung cancers in patients undergoing resection of an initial primary lung cancer
John M. Varlotto, R. Voland, Malcom McAvoy DeCamp, Paul Rava, Thomas J. Fitzgerald, Mark Maxfield, Ferian Lou, Paulo J. Oliveira, Rahul Sood, Jennifer Baima, Jianying ...> ;Lung Cancer. 2020 Jul 15
2 citations
The Incidence of Node-Positive Non-small-Cell Lung Cancer Undergoing Sublobar Resection and the Role of Radiation in Its Management.
John M. Varlotto, Isabel Cristina Martins Emmerick, Rick Voland, Malcom McAvoy DeCamp, John C. Flickinger, Debra Maddox, Christine Herbert, Molly Griffin, Paul Rava, T...> ;Frontiers in Oncology. 2020 May 26
1 citations
Rare gene fusion rearrangement SPTNB1-PDGFRB in an atypical myeloproliferative neoplasm
Vanessa Fiorini Furtado, Neeraj Saini, William V. Walsh, Venu Bathini, Patricia M. Miron> ;Molecular Cytogenetics. 2018 Oct 19
14 citations
Immunohistochemical expression and prognostic value of PD-L1 in Extrapulmonary small cell carcinoma: a single institution experience
Mohammed Salhab, Yazan Migdady, Melanie Donahue, Yiqin Xiong, Karen Dresser, William V. Walsh, Benjamin J. Chen, James Liebmann> ;Journal for Immunotherapy of Cancer. 2018 May 29
7 citations
The Role of Race and Economic Characteristics in the Presentation and Survival of Patients With Surgically Resected Non-Small Cell Lung Cancer.
John M. Varlotto, Kerri McKie, R. Voland, John C. Flickinger, Malcolm M. DeCamp, Debra Maddox, Paul Rava, Thomas J. Fitzgerald, William V. Walsh, Paulo J. Oliveira, Ne...> ;Frontiers in Oncology. 2018 May 14
20 citations
Population‐based differences in the outcome and presentation of lung cancer patients based upon racial, histologic, and economic factors in all lung patients and those...
John M. Varlotto, Richard Voland, Kerrie McKie, John C. Flickinger, Malcolm M. DeCamp, Debra Maddox, Paul Rava, Thomas J. Fitzgerald, Geoffrey Graeber, Negar Rassaei, ...> ;Cancer Medicine. 2018 Mar 13
6 citations
Randomized Phase 2 Trial of Pharmacodynamic Separation of Pemetrexed and Intercalated Erlotinib Versus Pemetrexed Alone for Advanced Nonsquamous, Non-small-cell Lung C...
Tianhong Li, Bilal Piperdi, William V. Walsh, Mimi Kim, Laurel A. Beckett, Rasim Gucalp, Missak Haigentz, Venu Bathini, Huiyu Wen, Kaili Zhou, Patricia Pasquinelli, Sr...> ;Clinical Lung Cancer. 2017 Jan 1
8 citations
Influence of plate-bone contact on cyclically loaded conically coupled locking plate failure.
Randi Rotne, Nicky Bertollo, William R. Walsh, Navneet K. Dhand, K. Voss, Kenneth A. Johnson> ;Injury. 2014 Mar 1
4 citations
A Phase II Trial of Cetuximab, Gemcitabine, 5-Fluorouracil, and Radiation Therapy in Locally Advanced Nonmetastatic Pancreatic Adenocarcinoma.
Volkan Cetin, Bilal Piperdi, Venu Bathini, William V. Walsh, Shakeeb Yunus, Jennifer F. Tseng, Giles F. Whalen, Wahid Wassef, Sidney P. Kadish, Thomas J. Fitzgerald, C...> ;Gastrointestinal Cancer Research. 2013 Jul 1
40 citations
Expression of CD25 independently predicts early treatment failure of acute myeloid leukaemia (AML)
Jan Cerny, Hongbo Yu, Muthalagu Ramanathan, Glen D. Raffel, William V. Walsh, Natasha Fortier, Lindsey Shanahan, Elizabeth O'Rourke, Jayde Bednarik, Bruce A. Barton, A...> ;British Journal of Haematology. 2013 Jan 1
25 citations
Phase-I/II Study of Bortezomib in Combination with Carboplatin and Bevacizumab as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer
Bilal Piperdi, William V. Walsh, Kendra J. Bradley, Zheng Zhou, Venu Bathini, Meredith Hanrahan-Boshes, Lloyd Hutchinson, Roman Perez-Soler> ;Journal of Thoracic Oncology. 2012 Jun 1
60 citations
Phase II study of obatoclax mesylate (GX15-070), a small-molecule BCL-2 family antagonist, for patients with myelofibrosis.
Sameer A. Parikh, Hagop M. Kantarjian, Aaron D. Schimmer, William V. Walsh, Ekatherine Asatiani, Khaled El-Shami, Elliott F. Winton, Srdan Verstovsek> ;Clinical Lymphoma, Myeloma & Leukemia. 2010 Aug 1
Anti-VEGF and anti-EGFR monoclonal antibodies (Mabs) in the first-line therapy for metastatic colorectal cancer: A meta-analysis.
Zhou Z, Walsh WV, Bathini VG, Piperdi B> ;J. Clin. Oncol.. 2009-05-20
2 citations
Hypertrophic pulmonary osteoarthropathy disappearance despite lung cancer relapse.
Jan Cerny, Robert Licho, P H Simkin, William V. Walsh> ;Southern Medical Journal. 2008 Sep 1
2577 citations
A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia
Michael B. Kastan, Qimin Zhan, Wafik S. El-Deiry, Tyler Jacks, William V. Walsh, Beverly Plunkett, Bert Vogelstein, Albert J. Fornace> ;Cell. 1992 Nov 13
1493 citations
Wild-type p53 is a cell cycle checkpoint determinant following irradiation.
Steven J. Kuerbitz, Beverly Plunkett, William V. Walsh, Michael B. Kastan> ;Proceedings of the National Academy of Sciences of the United States of America. 1992 Aug 15
Join now to see all

Professional Memberships

American Society of Clinical Oncology - ASCO
Member
American Society of Hematology - ASH
Member

Hospital Affiliations

UMass Memorial Medical CenterWorcester, Massachusetts